Neuroone Medical Technologies (NMTC) Notes Payables (2010 - 2024)

Neuroone Medical Technologies (NMTC) reported Notes Payables of $121896.0 for Q1 2024, down 5.59% sequentially from $129116.0 in Q3 2023.

Neuroone Medical Technologies (NMTC) Notes Payables (2010 - 2024) Analysis & Trends

Neuroone Medical Technologies has disclosed Notes Payables across 12 years of filings, most recently posting $121896.0 for Q1 2024.

  • Quarterly Notes Payables changed N/A year-over-year to $121896.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $121896.0 (changed N/A YoY) and the FY2023 annual result came in at $129116.0, changed N/A from the prior year.
  • Notes Payables retreated to $121896.0 in Q1 2024, from $129116.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $6.7 million in Q2 2020 and bottomed at $121896.0 in Q1 2024.
  • The 3-year median for Notes Payables is $1.0 million (2020), against an average of $2.6 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Neuroone Medical Technologies 26.73 Mn 23.93 Mn 990,264.00

Historic Data

Download Data
DateValue
Mar 31, 2024 121,896.00
Sep 30, 2023 129,116.00
Sep 30, 2020 1.01 Mn
Jun 30, 2020 6.73 Mn
Mar 31, 2020 4.92 Mn
Dec 31, 2019 5.19 Mn
Dec 31, 2018 1.66 Mn
Sep 30, 2018 1.39 Mn
Jun 30, 2018 1.13 Mn
Mar 31, 2018 369,124.00
Dec 31, 2017 2.17 Mn
Sep 30, 2017 1.46 Mn
Dec 31, 2016 50,000.00
Mar 31, 2016 17,634.00
Dec 31, 2015 13,619.00
Dec 31, 2013 22,000.00
Sep 30, 2013 26,500.00
Jun 30, 2013 25,000.00
Mar 31, 2013 21,000.00
Dec 31, 2012 2,000.00